| Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients A Asberg, A Humar, H Rollag, AG Jardine, H Mouas, MD Pescovitz, ... American Journal of Transplantation 7 (9), 2106-2113, 2007 | 462 | 2007 |
| The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients S Sagedal, KP Nordal, A Hartmann, S Sund, H Scott, M Degré, A Foss, ... American Journal of Transplantation 2 (9), 850-856, 2002 | 399 | 2002 |
| Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival S Sagedal, A Hartmann, KP Nordal, K Osnes, T Leivestad, A Foss, ... Kidney international 66 (1), 329-337, 2004 | 396 | 2004 |
| Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation J Hjelmesaeth, S Sagedal, A Hartmann, H Rollag, T Egeland, M Hagen, ... Diabetologia 47, 1550-1556, 2004 | 287 | 2004 |
| Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients A Asberg, A Humar, AG Jardine, H Rollag, MD Pescovitz, H Mouas, ... American Journal of Transplantation 9 (5), 1205-1213, 2009 | 203 | 2009 |
| A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft RECIPIENTS1 S Sagedal, KP Nordal, A Hartmann, M Degré, E Holter, A Foss, K Osnes, ... Transplantation 70 (8), 1166-1174, 2000 | 195 | 2000 |
| Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells H Sindre, GE Tjoonnfjord, H Rollag, T Ranneberg-Nilsen, OP Veiby, ... | 185 | 1996 |
| Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease O Manuel, A Åsberg, X Pang, H Rollag, VC Emery, JK Preiksaitis, ... Clinical infectious diseases 49 (8), 1160-1166, 2009 | 128 | 2009 |
| Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients HA Myhre, DH Dorenberg, KI Kristiansen, H Rollag, T Leivestad, A Åsberg, ... Transplantation 92 (2), 217-223, 2011 | 126 | 2011 |
| Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced β-cell damage J Hjelmesæth, F Müller, T Jenssen, H Rollag, S Sagedal, A Hartmann Nephrology Dialysis Transplantation 20 (11), 2311-2315, 2005 | 120 | 2005 |
| Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir G Boivin, N Goyette, H Rollag, AG Jardine, MD Pescovitz, A Asberg, J Ives, ... Antiviral therapy 14 (5), 697-704, 2009 | 113 | 2009 |
| The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response LF Lisboa, A Åsberg, D Kumar, X Pang, A Hartmann, JK Preiksaitis, ... Transplantation 91 (2), 231-236, 2011 | 112 | 2011 |
| Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in … RR Razonable, A Åsberg, H Rollag, J Duncan, D Boisvert, JD Yao, ... Clinical infectious diseases 56 (11), 1546-1553, 2013 | 101 | 2013 |
| Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients A Åsberg, AG Jardine, AA Bignamini, H Rollag, MD Pescovitz, ... American journal of transplantation 10 (8), 1881-1888, 2010 | 100 | 2010 |
| Viral safety of solvent/detergent‐treated plasma BG Solheim, H Rollag, JL Svennevig, O Arafa, E Fosse, U Bergerud Transfusion 40 (1), 84-90, 2000 | 98 | 2000 |
| Breast cancer, cytomegalovirus and Epstein–Barr virus: a nested case–control study B Cox, A Richardson, P Graham, RE Gislefoss, E Jellum, H Rollag British journal of cancer 102 (11), 1665-1669, 2010 | 86 | 2010 |
| Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade TG Valderhaug, J Hjelmesæth, H Rollag, T Leivestad, J Røislien, ... Transplantation 84 (9), 1125-1130, 2007 | 85 | 2007 |
| Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk S Sagedal, H Rollag, A Hartmann Clinical transplantation 21 (3), 309-313, 2007 | 83 | 2007 |
| An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes A Humar, A Asberg, D Kumar, A Hartmann, G Moussa, A Jardine, ... American Journal of Transplantation 9 (2), 374-381, 2009 | 77 | 2009 |
| Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study S Sagedal, KP Nordal, A Hartmann, K Midtvedt, A Foss, A Åsberg, ... Nephrology Dialysis Transplantation 18 (9), 1899-1908, 2003 | 76 | 2003 |
